Firstly I don’t think HDE is the ultimate pathway Anteris is looking for as there is an annual quota how many devices can be sold for profit each year if I read it correctly.
Secondly, if VIV is not something Anteris is looking for PMA ultimately then why are they making it available for the Special Access Program in Canada?
I suspect VIV might be incorporated in the EFS or pivotal study somehow?
Not advice, DYOR
- Forums
- ASX - By Stock
- AVR
- Ann: Exceptional Results in Second Valve-in-Valve Case
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$6.00

Ann: Exceptional Results in Second Valve-in-Valve Case, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.00 |
Change
0.000(0.00%) |
Mkt cap ! $92.99M |
Open | High | Low | Value | Volume |
$6.00 | $6.06 | $6.00 | $12.63K | 2.093K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83 | $6.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.09 | 1690 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83 | 6.000 |
2 | 342 | 5.860 |
2 | 625 | 5.850 |
1 | 857 | 5.830 |
1 | 344 | 5.800 |
Price($) | Vol. | No. |
---|---|---|
6.090 | 1690 | 1 |
6.100 | 927 | 2 |
6.140 | 1490 | 1 |
6.150 | 218 | 1 |
6.160 | 92 | 1 |
Last trade - 11.30am 24/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |